Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (641-650 of 903) with videos related to

Pageof 91
Sort By:
Neurobiology of Aging|February 10, 2015
Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's diseaseEva Louwersheimer, Alfredo Ramirez, Carlos Cruchaga, et al.
Acta Neuropathologica|August 19, 2024
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseasesFrederique J Hart de Ruyter, Manon J A P Evers, Tjado H J Morrema, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2018
Assessing Amyloid Pathology in Cognitively Normal Subjects Using <sup>18</sup>F-Flutemetamol PET: Comparing Visual Reads and Quantitative MethodsLyduine E Collij, Elles Konijnenberg, Juhan Reimand, et al.
The Lancet. Neurology|July 10, 2007
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 22, 2022
No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controlsJurre den Haan, Frederique J Hart de Ruyter, Benjamin Lochocki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 7, 2022
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individualsJarith L Ebenau, Denise Visser, Sander C J Verfaillie, et al.
Frontiers in Human Neuroscience|October 7, 2015
Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's diseaseAnne Hafkemeijer, Christiane Möller, Elise G P Dopper, et al.
Dementia and Geriatric Cognitive Disorders|October 17, 2015
Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome CohortWelmoed A Krudop, Annemiek Dols, Cora J Kerssens, et al.
Neuropsychologia|May 11, 2019
High amyloid burden is associated with fewer specific words during spontaneous speech in individuals with subjective cognitive declineSander C J Verfaillie, Jurriaan Witteman, Rosalinde E R Slot, et al.
Pageof 91

Showing results (641-650 of 903) with videos related to

Sort By:
Pageof 91
Neurobiology of Aging|February 10, 2015
Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's diseaseEva Louwersheimer, Alfredo Ramirez, Carlos Cruchaga, et al.
Acta Neuropathologica|August 19, 2024
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseasesFrederique J Hart de Ruyter, Manon J A P Evers, Tjado H J Morrema, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2018
Assessing Amyloid Pathology in Cognitively Normal Subjects Using <sup>18</sup>F-Flutemetamol PET: Comparing Visual Reads and Quantitative MethodsLyduine E Collij, Elles Konijnenberg, Juhan Reimand, et al.
The Lancet. Neurology|July 10, 2007
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 22, 2022
No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controlsJurre den Haan, Frederique J Hart de Ruyter, Benjamin Lochocki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 7, 2022
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individualsJarith L Ebenau, Denise Visser, Sander C J Verfaillie, et al.
Frontiers in Human Neuroscience|October 7, 2015
Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's diseaseAnne Hafkemeijer, Christiane Möller, Elise G P Dopper, et al.
Dementia and Geriatric Cognitive Disorders|October 17, 2015
Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome CohortWelmoed A Krudop, Annemiek Dols, Cora J Kerssens, et al.
Neuropsychologia|May 11, 2019
High amyloid burden is associated with fewer specific words during spontaneous speech in individuals with subjective cognitive declineSander C J Verfaillie, Jurriaan Witteman, Rosalinde E R Slot, et al.
Pageof 91